FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-κB/IL-6 signaling pathway.
Overview
- Neurosurgery Center, Department of Neuro-oncological Surgery, The National Key Clinical Specialty, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases, Ministry of Education, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Zhujiang Hospital Institute for Brain Science and Intelligence, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282 China
- Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province China
- Department of Pathology, Shunde Hospital, Southern Medical University, (The First People’s Hospital of Shunde), Foshan, China
- Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
- Department of Radiology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China
- Department of Radiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
- Department of Neurosurgery, School of Medicine, The Sixth Affiliated Hospital of South China University of Technology (Nanhai District People’s Hospital of Foshan), Foshan, 528200 China
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE53733, at NCBI GEO; found in the text, “FAM135B suppresses angiogenesis by inhibiting…”
Data availability statement
The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- no repository, dataset or request procedure was recognized in it
Read it in the paper: doi.org/10.1186/s12967-026-08397-3.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 14 authors, 5 keywords, 16 MeSH terms, 2 funders, 26 references.
Cite
This paper
Wang, C., Zhang, F., Hao, L., Zhang, Y., Feng, C., Weng, N., Hu, P., Lin, W., Chen, T., Wang, T., Zhang, Y., Ke, Y., Zhao, L., & Chen, Z. (2026). FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-κB/
BibTeX
@article{wang2026fam135b
author = {Wang, Chuangyuan and Zhang, Fabing and Hao, Liwei and Zhang, Yujie and Feng, Chenya and Weng, Nuozhou and Hu, Peiqian and Lin, Wanmei and Chen, Taoliang and Wang, Tianwei and Zhang, Yinian and Ke, Yiquan and Zhao, Liang and Chen, Zetao},
title = {{FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-κB/
journal = {Journal of translational medicine},
year = {2026},
month = jun,
volume = {24},
number = {1},
pages = {1046},
publisher = {BMC},
issn = {1479-5876},
doi = {10.1186/
url = {https://
pmid = {42260484},
pmcid = {PMC13471341}
}
RIS
TY - JOUR
AU - Wang, Chuangyuan
AU - Zhang, Fabing
AU - Hao, Liwei
AU - Zhang, Yujie
AU - Feng, Chenya
AU - Weng, Nuozhou
AU - Hu, Peiqian
AU - Lin, Wanmei
AU - Chen, Taoliang
AU - Wang, Tianwei
AU - Zhang, Yinian
AU - Ke, Yiquan
AU - Zhao, Liang
AU - Chen, Zetao
TI - FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-κB/
T2 - Journal of translational medicine
J2 - J Transl Med
PY - 2026
DA - 2026/
VL - 24
IS - 1
SP - 1046
SN - 1479-5876
PB - BMC
DO - 10.1186/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1186/
"type": "article-journal",
"title": "FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-κB/
"container-title": "Journal of translational medicine",
"author": [
{
"family": "Wang",
"given": "Chuangyuan"
},
{
"family": "Zhang",
"given": "Fabing"
},
{
"family": "Hao",
"given": "Liwei"
},
{
"family": "Zhang",
"given": "Yujie"
},
{
"family": "Feng",
"given": "Chenya"
},
{
"family": "Weng",
"given": "Nuozhou"
},
{
"family": "Hu",
"given": "Peiqian"
},
{
"family": "Lin",
"given": "Wanmei"
},
{
"family": "Chen",
"given": "Taoliang"
},
{
"family": "Wang",
"given": "Tianwei"
},
{
"family": "Zhang",
"given": "Yinian"
},
{
"family": "Ke",
"given": "Yiquan"
},
{
"family": "Zhao",
"given": "Liang"
},
{
"family": "Chen",
"given": "Zetao"
}
],
"container-title-short":
"volume": "24",
"issue": "1",
"page": "1046",
"DOI": "10.1186/
"PMID": "42260484",
"PMCID": "PMC13471341",
"ISSN": "1479-5876",
"publisher": "BMC",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
8
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.3390/biology15080633
- Development and Validation of a Toxoplasma Infection-Associated Risk Model for Prognostic Stratification and Treatment Guidance in Glioma.Journal: BiologyIn common: other condition, 4 references
- [2] doi:10.1002/1878-0261.70223
- EDNRB-dependent endothelin signaling reduces proliferation and promotes proneural-to-mesenchymal
transition in gliomas. Journal: Molecular oncologyIn common: other condition, cellular / molecular, 3 references - [3] doi:10.3390/cancers18132092
- TGFB2 as a Prognostic Biomarker Associated with Myeloid-Enriched, Multi-Checkpoint-Activat
ed Immunosuppression in Diffuse Glioma: A Multi-Cohort Transcriptomic Study. Journal: CancersIn common: other condition, 3 references - [4] doi:10.1038/s12276-026-01801-4 [code]
- Putative glioblastoma origin-like cells in the subventricular zone: isolation and characterization.Journal: Experimental & molecular medicineIn common: other condition, mouse, cellular / molecular, 2 references
- [5] doi:10.1080/10717544.2026.2660007
- Angiopep-2-decorated bacterial outer membrane vesicles penetrate the blood-brain barrier for glioblastoma chemo-immunotherapy.Journal: Drug deliveryIn common: other condition, mouse, cellular / molecular, 2 references
- [6] doi:10.1016/j.xcrm.2026.102850 [code]
- Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma.Journal: Cell reports. MedicineIn common: other condition, mouse, 2 references
- [7] doi:10.3390/ijms27167240
- 1-Piperidine Propionic Acid Inhibits PAR2/
SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness. Journal: International journal of molecular sciencesIn common: other condition, mouse, cellular / molecular, 2 references - [8] doi:10.1080/2162402x.2026.2656053
- PARP7 inhibition and a STING agonist potentiate radiation-induced immunogenicity in glioblastoma.Journal: OncoimmunologyIn common: other condition, mouse, cellular / molecular, 2 references
- [9] doi:10.1186/s12967-026-08266-z [code]
- Single-cell multi-omic integration analysis prioritizes druggable genes and reveals cell-type-specific causal effects in glioblastomagenesis.Journal: Journal of translational medicineIn common: other condition, cellular / molecular, 2 references
- [10] doi:10.1080/17501911.2026.2691031
- Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis.Journal: EpigenomicsIn common: other condition, cellular / molecular, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.